机构:[1]Guangdong Provincial Key Laboratory of New Chinese Medicinal Development and Research, Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China[2]The First Affiliated Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, 12 Airport Road, Baiyun District, Guangzhou 510405, China深圳市中医院深圳医学信息中心[3]Dongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Dongguan 523808, China[4]Higher Education Institute and Development Research of Chinese Medicine, 12 Airport Road, Baiyun District, Guangzhou 510405, China
Excessive alcohol consumption leads to serious liver injury, associating with oxidative stress and inflammatory response. Previous study has demonstrated that polydatin (PD) exerted antioxidant and anti-inflammatory effects and attenuated ethanol-induced liver damage, but the research remained insufficient. Hence, this experiment aimed to evaluate the hepatoprotective effect and potential mechanisms of PD on ethanol-induced hepatotoxicity. Our results showed that PD pretreatment dramatically decreased the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) in the serum, suppressed the malonaldehyde (MDA) and triglyceride (TG) content and the production of reactive oxygen species (ROS), and enhanced the activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT), andalcohol dehydrogenase (ADH), and aldehyde dehydrogenase (ALDH), paralleled by an improvement of histopathology alterations. The protective effect of PD against oxidative stress was probably associated with downregulation of cytochrome P450 2E1 (CYP2E1) and upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2) and its target gene haem oxygenase-1 (HO-1). Moreover, PD inhibited the release of proinflammatory cytokines (TNF-α, IL-1β, and IL-6) via downregulating toll-like receptor 4 (TLR4) and nuclear factor kappa B (NF-κB) p65. To conclude, PD pretreatment protects against ethanol-induced liver injury via suppressing oxidative stress and inflammation.
基金:
Hong Kong, Macao,and Taiwan Science & Technology Cooperation Program
of China (no. 2014DFH30010), Science and Technology
Major Project of Guangdong Province (no. 2013A022100001),
Science and Technology Planning Project of Guangdong
Province, China (nos. 2013B090600007, 2013B090600010,
and 2013B090600026), Guangdong International Cooperation Project (no. 2013508102016), Guangdong Provincial
Department of Education Feature Innovation Project (no.
2016KTSCX018), and Key Disciplines Construction Projects
of High-level University of Guangdong Province.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类|4 区医学
小类|3 区全科医学与补充医学
最新[2025]版:
无
第一作者:
第一作者机构:[1]Guangdong Provincial Key Laboratory of New Chinese Medicinal Development and Research, Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
共同第一作者:
通讯作者:
通讯机构:[1]Guangdong Provincial Key Laboratory of New Chinese Medicinal Development and Research, Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China[3]Dongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Dongguan 523808, China
推荐引用方式(GB/T 7714):
Huang Qiong-Hui,Xu Lie-Qiang,Liu Yu-Hong,et al.Polydatin Protects Rat Liver against Ethanol-Induced Injury: Involvement of CYP2E1/ROS/Nrf2 and TLR4/NF-κB p65 Pathway.[J].Evidence-based complementary and alternative medicine : eCAM.2017,2017:7953850.doi:10.1155/2017/7953850.
APA:
Huang Qiong-Hui,Xu Lie-Qiang,Liu Yu-Hong,Wu Jia-Zhen,Wu Xue...&Xie You-Liang.(2017).Polydatin Protects Rat Liver against Ethanol-Induced Injury: Involvement of CYP2E1/ROS/Nrf2 and TLR4/NF-κB p65 Pathway..Evidence-based complementary and alternative medicine : eCAM,2017,
MLA:
Huang Qiong-Hui,et al."Polydatin Protects Rat Liver against Ethanol-Induced Injury: Involvement of CYP2E1/ROS/Nrf2 and TLR4/NF-κB p65 Pathway.".Evidence-based complementary and alternative medicine : eCAM 2017.(2017):7953850